Prospective Pilot Study of <sup>18</sup>F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas
Matthew F. Covington, John M. Hoffman, Kathryn A. Morton, Brandon Buckway, Kenneth M. Boucher, Regina E. Rosenthal, Jane Porretta, Kirstyn E. Brownson, Cindy Matsen, Christos Vaklavas, John H. Ward, Mei Wei, Saundra S. Buys, Namita Chittoria, Ellen D. Yakish, Zane G. Archibald, Lance D. Burrell, Regan Butterfield, Jeffrey T. Yap
Abstract
BACKGROUND. PET/CT with 18F-fluoroestradiol (FES) (FDA-approved in 2020) depicts tissues expressing estrogen receptor (ER). Invasive lobular carcinoma (ILC) is commonly ER positive.
Topics & Concepts
MedicineNuclear medicineRadiologyMedical Imaging Techniques and ApplicationsRadiomics and Machine Learning in Medical ImagingHead and Neck Cancer Studies